CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 100 filers reported holding CHEMOCENTRYX INC in Q1 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $826,000 | +187.8% | 62,730 | +197.2% | 0.06% | +172.7% |
| Q1 2018 | $287,000 | -67.7% | 21,104 | -77.8% | 0.02% | -66.2% |
| Q2 2017 | $888,000 | +71.8% | 94,897 | +33.4% | 0.06% | +80.6% |
| Q1 2017 | $517,000 | -33.4% | 71,142 | -32.2% | 0.04% | -33.3% |
| Q4 2016 | $776,000 | +31.3% | 104,999 | +7.2% | 0.05% | +25.6% |
| Q3 2016 | $591,000 | +74.9% | 97,975 | +30.1% | 0.04% | +87.0% |
| Q2 2016 | $338,000 | -81.0% | 75,299 | -76.5% | 0.02% | -87.2% |
| Q3 2013 | $1,778,000 | – | 319,868 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |